I enjoyed sharing a panel to discuss hemp legal issues with my friends and fellow attorneys at the Southern US Hemp Conference and Expo this week in Myrtle Beach, South Carolina.
Growing hemp in the US will be different next year, whether or not Congress finally gets its act together and passes the 2018 Farm Bill with its new hemp provisions.
One thing that appears to have gone unnoticed in all of the front page articles is the fact that Canada is not the largest jurisdiction in the world in which recreational (adult use) marijuana is lawful.
To say that all CBD is unlawful because it is a derivative of Cannabis is nonsensical; there are lawful and unlawful types of Cannabis.
The “Regulatory Status of Cannabidiol in the United States: A Perspective”, an article I co-wrote with Dr. Jamie Corroon, was published this week in Cannabis and Cannabinoid Research, a peer reviewed journal.
Congress has not yet enacted the 2018 Farm Bill. It is likely to pass within the next 8 weeks or so. However, what is the current legal status of industrial hemp now that the 2014 Farm Act has expired?
The DEA has rescheduled Epidiolex, a product containing CBD derived from marijuana, from schedule 1 to schedule 5.
How upset will you be if someone steals your company name or the name of your best selling item?
Marijuana retailers in Oregon have until April 1, 2019 to become compliant with the new labeling rules.
The Ohio Board of Pharmacy issued two Guidance Documents regarding CBD this week that have caused an uproar. Is the Pharmacy Board right?